The deal includes an upfront cash payment of $380 per share, representing a 50% premium over Abiomed’s closing stock price the day before the announcement.

Nearly 334,000 physicians, nurse practitioners, physician assistants and other clinicians left the workforce in 2021 due to retirement, burnout and pandemic-related stressors, according to new data.

Drug shortages aren’t going away any time soon, according to Bindiya Vakil, CEO of Resilinc, a California-based firm that helps companies from a variety of industries mitigate supply chain problems. While shortages of high-profile drugs such as Adderall and amoxicillin have garnered headlines recently, Vakil points to a recent FDA warning that has the potential for more far-reaching consequences.

As the FDA convenes an advisory committee meeting to discuss recent studies showing that many pulse oximeters are less effective when used on patients with darker skin, BioIntelliSense is getting a head start on addressing the issue.

Unity Biotechnology seems to have gotten its crew together behind a common goal in ophthalmology, with the biotech announcing today that its treatment for diabetic macular edema improved vision in a mid-stage trial.

VillageMD, which is majority owned by Walgreens Boots Alliance, is exploring a potential deal to merge with medical practice Summit Health, the parent company of urgent care clinic chain CityMD, Bloomberg reported Sunday.

Medicago, a Canadian vaccine maker that scored the first approval for a plant-based COVID-19 vaccine earlier this year, will slash 62 jobs at its Durham, North Carolina, site by the year-end. The move is part of a "new approach" to manufacturing its vaccines, Medicago's CEO Toshifumi Tada told Fierce Pharma.